Suboxone may be considered for selected chronic pain patients when opioid safety, tolerance, dependence risk, or long-term medication concerns are part of care.
Learn how Dr. Aranguren explains Suboxone, when it may be appropriate for pain management or opioid dependence, and how it can be safely incorporated into a personalized treatment plan.
Our team organizes conditions and treatments into related zones of expertise to make it easier to explore the care paths most relevant to your symptoms and goals.
Use the zone tags above to browse dedicated pages for each focus area, including services, providers, and what to expect during treatment.
If you鈥檝e been dealing with chronic pain for a long time, especially after being on opioid medications for years, you may have heard about a medication called Suboxone and wondered why it鈥檚 sometimes used in pain management.
Suboxone is a medication that contains buprenorphine, which works differently from traditional opioid medications. In the right patients, it can help reduce pain, stabilize the nervous system, and lower some of the risks that come with long-term opioid use.
One thing many people don鈥檛 realize is that chronic pain and the nervous system are deeply connected. Over time, high-dose or long-term opioid use can sometimes make the nervous system more sensitive rather than less sensitive, a process called opioid-induced hyperalgesia. For some patients, transitioning to buprenorphine-based treatment can provide more stable pain control with less fluctuation, less sedation, and a lower risk profile.
Suboxone is also commonly used in the treatment of opioid dependence, which is why some patients feel nervous or hesitant when they hear the name. But in pain medicine, we may use buprenorphine thoughtfully as part of a broader strategy to improve function and quality of life. My approach is always individualized. The goal is not simply to 鈥渢ake medications away,鈥� but to help patients feel safer, more functional, and more stable over time.
Treatment decisions are based on the full picture: pain patterns, nervous system sensitivity, medication history, goals, and overall health.
If you鈥檝e been struggling with chronic pain, medication side effects, or feeling stuck in a difficult pain cycle, Suboxone or buprenorphine-based therapy may be one option worth discussing as part of a comprehensive care plan.
Suboxone is a medication that contains buprenorphine and naloxone. It is widely known for opioid use disorder treatment, but buprenorphine-based strategies may also be considered in selected pain care situations when opioid safety, tolerance, dependence concerns, or long-term opioid therapy risks are part of the clinical picture.
At 91视频, Suboxone for pain management NYC care is not automatic and is not appropriate for every patient. It requires diagnosis-first evaluation, medication review, risk assessment, careful transition planning when needed, monitoring, and coordination with other clinicians when appropriate.
MPM specialists evaluate whether Suboxone or another buprenorphine-based strategy may be appropriate by reviewing the patient鈥檚 pain diagnosis, opioid history, current medications, prior treatment response, safety risks, functional goals, and concerns about tolerance, dependence, constipation, sedation, or unstable pain control.
The team also considers whether the patient has opioid use disorder history, autoimmune-related pain, abdominal pain, gastroparesis, centralized pain, or complex chronic pain requiring coordinated care. Suboxone initiation and transitions from full opioid agonists require careful timing and supervision because incorrect timing can precipitate withdrawal.
Suboxone is often associated with addiction medicine, which can create confusion or stigma for chronic pain patients. Taking Suboxone does not automatically mean a patient has addiction. It does mean that the medication requires careful clinical evaluation, monitoring, and clear treatment goals.
In selected pain care situations, buprenorphine-based medication may be considered when traditional opioid therapy is creating safety concerns, tolerance, dependence concerns, constipation, sedation, unstable pain control, or long-term risk. It may also be relevant for patients already taking opioids who need a more structured plan. MPM approaches this discussion carefully and without judgment. Suboxone is not a default pain medication, and it does not replace diagnosis, non-opioid medications, procedures, pain psychology, infusions, rehabilitation, or specialist care when those are needed. It is one possible tool within a broader safety-focused medication plan.
Suboxone and buprenorphine-based pain management may intersect with MPM鈥檚 expertise in Complex Chronic Pain and Autoimmune and Inflammatory pain. Patients with complex chronic pain may have years of medication trials, opioid exposure, side effects, tolerance, dependence concerns, or incomplete relief. Patients with autoimmune-related pain, abdominal pain, chronic constipation, gastroparesis, centralized pain, or neurological symptoms may require special caution when opioid-based medications are considered.
MPM evaluates Suboxone within the full clinical picture. The team considers whether the pain diagnosis has been fully assessed, whether non-opioid and interventional options have been considered, whether opioid-related risk is present, and whether coordination with addiction medicine, psychiatry, rheumatology, GI, primary care, or other clinicians may be needed.
During a Suboxone pain management evaluation, MPM reviews the patient鈥檚 diagnosis, opioid history, current medications, prior treatment response, side effects, constipation, sedation, withdrawal symptoms, mental health history, substance use concerns, and functional goals. Patients should be prepared to discuss which medications they are taking, when they take them, what has helped, what has caused side effects, and whether they are concerned about tolerance, dependence, or safety.
If Suboxone is considered, MPM discusses risks, benefits, alternatives, monitoring, and timing. A transition from full opioid therapy to buprenorphine-based care requires careful planning to reduce withdrawal risk. Ongoing monitoring may include medication reconciliation, prescription monitoring, controlled-substance expectations, side effect review, liver considerations, and coordination with other clinicians when appropriate.
I cannot say enough good things about 91视频. From the moment I walked in, I felt truly cared for and taken seriously. Dr. Nino Mikaberidze, Director of Rheumatology, is exceptional 鈥� knowledgeable, compassionate, and incredibly thorough. She takes the time to listen, explains every...
The best care I've received as a chronic pain patient. I traveled from out of state to visit 91视频 because I could not find knowledgeable doctors in my hometown for my hypermobility, and Ehlers-Danlos syndrome symptoms and comorbidities. Let me tell you, it was worth every travel e...
I was injured in a bicycle accident over 8 years ago. I鈥檝e suffered throughout the years since my accident with nothing seeming to work. PT, Yoga, lifestyle changes, NOTHNG! I finally made an appointment with Dr Kane and I鈥檓 feeling an improvement in my life. I no longer stay up all night in pain, a...
One of the best experiences, if not the best, I have ever had at the doctor鈥檚 office. From the front desk to the nurses to the PA assisting the doctor this was a great experience. Dr.Nino actually listened to me and came up with a game plan. Would recommend this practice to as many people as I could...
I have very unique & severe nerve pain from CRPS which has no known specific cure. Dr. Siefferman has a huge tool box, far greater than the other 23 Drs. I have seen. He saved me from jumping off a bridge and continues to help me with both treatments and advice. Dr. S. is in a different league!
After two years of searching and feeling lost and let down, I finally found real help at 91视频. With Dr. Siefferman, Adam Rosenberg, Dr. Mikaberidze, and the whole team, I feel heard, supported and understood. Every symptom is being considered and I鈥檓 finally getting answers with m...
Why is Dr Dr. Tayyaba Ahmed one of the top pevic Floor specialists - 1- She wants to know a full history of what led the patient to get to this point. 2 - She listens intensley to the patient 3- She does not rush you 4- Extremely skilled at giving pelvic floor injections 5- I thank my luck stars she...
The staff was friendly and helpful. Dr. Siefferman was thoughtful, listened, asked questions and proposed simple safe ways to come to further conclusions regarding my pain and discomfort. The office staff including Dr. Siefferman is responsive even after the initial in-person visit. Very pleased.
Dr. Siefferman is a brilliant provider. While my pain is still a work in progress, Dr Siefferman always gives me options and explains his reasoning behind things. He listens to my feedback and concerns. I never feel rushed; and am grateful he works to meet me where I am. I highly recommend him.
What a great find! They listen to me, I listen to them and the diagnosis is made and a plan developed to develop an approach to treat all of my chronic pain. I wish I could have discovered this type of treatment sooner. This doctor and group give me hope.
Suboxone is a medication that contains buprenorphine and naloxone. Buprenorphine is a partial opioid medication, and naloxone is included to reduce misuse risk when taken inappropriately. Suboxone is widely used in opioid use disorder treatment, but buprenorphine-based strategies may also be considered in selected pain care situations. At MPM, Suboxone for pain management NYC care requires careful evaluation, monitoring, and discussion of risks, benefits, alternatives, and goals.
Suboxone contains buprenorphine, but it is not exactly the same as buprenorphine alone. Suboxone is a combination of buprenorphine and naloxone. Buprenorphine may also exist in other formulations used for different medical purposes. The right formulation depends on the clinical situation, diagnosis, opioid history, safety risks, and treatment goals. MPM reviews these factors before considering any buprenorphine-based medication plan.
Suboxone may be considered for selected pain patients, especially when opioid safety, tolerance, dependence concerns, long-term opioid therapy risks, or unstable pain control are part of the clinical picture. It is not a default pain medication and is not appropriate for every patient. MPM evaluates the diagnosis, prior opioid exposure, current medications, safety factors, functional goals, and whether other pain treatments should be used instead of, or alongside, Suboxone.
Suboxone is commonly used to treat opioid use disorder, but buprenorphine-based strategies may also be considered in selected pain management contexts. These uses require different clinical framing and careful documentation. A pain patient being evaluated for Suboxone does not automatically have addiction. At the same time, opioid use disorder history, dependence concerns, or misuse risk must be addressed honestly and safely. MPM uses nonjudgmental, safety-focused communication when discussing these issues.
Suboxone contains buprenorphine, which works differently from many traditional full opioid agonists. It binds strongly to opioid receptors and has a different risk profile, but it still requires careful monitoring. It can cause sedation, constipation, dependence, withdrawal, medication interactions, respiratory depression in certain situations, and overdose risk, especially with sedatives or alcohol. MPM may consider Suboxone when traditional opioid therapy raises safety concerns, but it is not risk-free and is not automatically safer for every patient.
Suboxone may help selected chronic pain patients, particularly when opioid therapy has become unsafe, unstable, poorly tolerated, or complicated by tolerance or dependence concerns. It may be considered as part of a broader medication management plan. It does not cure chronic pain, autoimmune pain, abdominal pain, central pain syndromes, neurological conditions, or inflammatory disease. MPM evaluates whether the pain diagnosis and medication history support Suboxone or whether other treatments may be more appropriate.
A candidate may be a selected chronic pain patient with prior opioid exposure, opioid safety concerns, tolerance, dependence concerns, difficulty with long-term opioid therapy, or a need for a more structured medication plan. Candidacy depends on diagnosis, medical history, current medications, mental health history, substance use history, liver considerations, constipation risk, sedation risk, and treatment goals. MPM reviews whether Suboxone fits the patient鈥檚 full clinical picture and whether other specialists should be involved.
Suboxone may be considered for some patients already taking opioids, but transitions require careful timing and supervision. Starting Suboxone too soon after certain full opioid medications can precipitate withdrawal, which can be severe and distressing. Patients should not attempt to switch on their own. MPM reviews the current opioid regimen, dose, timing, withdrawal risk, safety concerns, and clinical goals before considering any transition to buprenorphine-based care.
Suboxone may reduce certain opioid-related risks for selected patients, but it is not risk-free. It may be considered when traditional opioid therapy creates concerns about tolerance, dependence, sedation, unstable pain control, or long-term safety. However, Suboxone can still cause side effects, dependence, withdrawal, medication interactions, and respiratory depression in certain situations. MPM evaluates whether Suboxone meaningfully improves the risk-benefit profile for the individual patient.
Yes. Suboxone can cause constipation, although the degree varies by patient. This is especially important for patients with chronic constipation, abdominal pain, stomach pain, gastroparesis, or GI motility concerns. MPM reviews bowel symptoms, current medications, hydration, diet, mobility, and other GI risk factors before recommending opioid-based medication strategies. If Suboxone is used, constipation prevention and monitoring may be part of the care plan.
Possible side effects include sedation, dizziness, nausea, constipation, sweating, headache, sleep disturbance, dry mouth, liver enzyme changes, dependence, withdrawal, medication interactions, diversion risk, respiratory depression, and overdose risk, especially when combined with alcohol, benzodiazepines, sedatives, or other medications that affect breathing or alertness. Starting Suboxone at the wrong time after certain opioids can precipitate withdrawal. MPM reviews risks, interactions, monitoring needs, and alternatives before recommending treatment.
Yes. Suboxone is a controlled medication and requires monitoring. This may include medication reconciliation, prescription monitoring, controlled-substance expectations, side effect review, liver considerations, sedation risk review, constipation management, overdose risk discussion, and coordination with other clinicians. Depending on the situation, urine drug testing or additional monitoring may be appropriate. MPM uses monitoring to support safety and clarity, not to stigmatize the patient.
Yes. Suboxone may be combined with other pain treatments when clinically appropriate. This may include non-opioid medication management, procedures, pain psychology, biofeedback, infusions, ketamine therapy, lidocaine and ketamine infusions, physical rehabilitation, or specialist coordination. Pain psychology can help patients manage fear, medical trauma, flare patterns, coping, function, and opioid-related concerns. MPM uses Suboxone only as one possible component of a broader diagnosis-first pain plan.
Suboxone may not be appropriate when the diagnosis is unclear, the risks outweigh potential benefits, the patient is not ready or medically suited for transition, or another treatment pathway is safer. It may require caution or avoidance with severe liver disease, significant respiratory risk, medication interactions, severe uncontrolled psychiatric instability, certain substance use concerns, pregnancy or breastfeeding considerations, or unstable medical conditions. Urgent care is needed for trouble breathing, severe sedation, confusion, suspected overdose, blue lips, inability to wake, chest pain, severe withdrawal symptoms, severe abdominal pain, persistent vomiting, jaundice, or rapidly worsening symptoms.
Before care begins, our team helps patients understand the practical side of treatment, including insurance verification, out-of-network benefits, cost-share estimates, self-pay options, and billing questions. We believe patients should have as much clarity as possible before moving forward.
Suboxone is a medication that contains buprenorphine and naloxone. It is commonly associated with opioid use disorder treatment, but buprenorphine-based medication strategies may also be considered in selected chronic pain situations. This can be confusing for patients who have pain and worry that Suboxone carries stigma.
At 91视频 (MPM), Suboxone for pain management NYC care is approached carefully and without judgment. Considering Suboxone does not automatically mean a patient has addiction. It means the medication plan requires a thoughtful review of pain diagnosis, opioid history, safety concerns, tolerance, dependence risk, side effects, function, and alternatives.
Suboxone contains buprenorphine, which is a partial opioid medication. It interacts with opioid receptors differently from many traditional full opioid agonists. This different profile may make buprenorphine-based strategies useful for selected patients when long-term opioid therapy is creating concerns, but it does not make Suboxone risk-free.
Suboxone can still cause sedation, dizziness, nausea, constipation, sweating, headache, sleep disturbance, medication interactions, dependence, withdrawal, and respiratory depression in certain situations. It also requires careful monitoring and should not be started, stopped, or changed without medical guidance.
Suboxone may be considered for selected chronic pain patients who are already taking opioids, have opioid tolerance, have dependence concerns, experience unstable pain control, or are dealing with opioid-related side effects such as sedation or constipation. It may also be considered when traditional opioid therapy carries too much long-term risk and a different medication strategy may be safer.
Patients with autoimmune-related pain, abdominal pain, stomach pain, gastroparesis, chronic constipation, centralized pain, or neurological symptoms require additional caution. Suboxone does not cure these conditions and may still affect the gastrointestinal system, mood, alertness, and medication safety.
Transitioning from full opioid therapy to Suboxone or another buprenorphine-based plan requires careful timing. If Suboxone is started too soon after certain opioids, it can precipitate withdrawal. This can cause severe discomfort and may include agitation, nausea, sweating, pain flare, anxiety, GI symptoms, and other withdrawal symptoms.
MPM reviews the current opioid medication, dose, schedule, duration of use, withdrawal history, safety concerns, and treatment goals before considering a transition. The plan may involve coordination with primary care, psychiatry, addiction medicine, or other specialists when appropriate.
Many patients are concerned that Suboxone will make them feel labeled. MPM approaches this discussion directly and respectfully. Chronic pain patients can have legitimate pain needs and still benefit from safer opioid-related medication strategies. Opioid tolerance, dependence, and addiction are not the same thing, and each requires a different clinical response.
Suboxone may be part of a function-focused pain plan that also includes non-opioid medications, procedures, infusions, pain psychology, biofeedback, rehabilitation, rheumatology care, neurology care, GI care, or other specialist coordination. Pain psychology may be especially helpful for patients dealing with medical trauma, fear of withdrawal, opioid stigma, flare anxiety, or long-term pain distress.
Suboxone requires monitoring. This may include medication reconciliation, prescription monitoring, controlled-substance expectations, side effect review, liver considerations, sedation risk review, constipation management, overdose risk discussion, and coordination with other clinicians. Some patients may also need urine drug testing or controlled-substance agreements depending on the care plan.
Risks may include sedation, dizziness, nausea, constipation, sweating, headache, sleep disturbance, liver enzyme changes, respiratory depression, medication interactions, dependence, withdrawal, diversion risk, and overdose risk, especially when combined with alcohol, benzodiazepines, sedatives, or other medications that affect breathing.
Suboxone may not be appropriate when risks outweigh benefits, when the diagnosis is unclear, when another treatment is more appropriate, or when transition timing cannot be managed safely. It may require caution or avoidance in patients with severe liver disease, significant breathing problems, medication interactions, severe uncontrolled psychiatric instability, substance use concerns, pregnancy or breastfeeding considerations, or unstable medical conditions.
Patients should seek urgent care for trouble breathing, severe sedation, confusion, suspected overdose, blue lips, inability to wake, chest pain, severe allergic reaction, suicidal thoughts, severe withdrawal symptoms, severe abdominal pain, persistent vomiting, bowel obstruction symptoms, yellowing of the skin or eyes, new neurological deficits, bowel or bladder dysfunction, saddle anesthesia, or rapidly worsening symptoms.
For selected patients, Suboxone may be a useful part of safer chronic pain medication management. MPM鈥檚 role is to determine whether it fits the diagnosis, opioid history, safety profile, and functional goals within a coordinated pain care plan.
